期刊文献+

妊娠高血压综合征患者胎盘床血管内皮素(ET-1)的表达与临床意义 被引量:3

THE EXPRESSION AND CLINICAL SIGNIFICANCE OF ET-1 IN PLACENTAL BED SPIRAL ARTERY OF EDEMA-HYPERTENSION-PROTEINURIA SYNDROME PATIENTS
暂未订购
导出
摘要 目的:观察妊娠高血压综合征(妊高征)患者胎盘床螺旋动脉血管内皮素(ET-1)的表达情况,探讨妊高征的发病机理。方法:收集正常妊娠病例30例、妊高征70例(其中轻度30例,中度20例,重度20例),采用免疫组织化学方法观察妊高征和正常妊娠胎盘床蜕膜段和肌层螺旋动脉ET-1的表达情况。结果:ET-1在妊高征胎盘床蜕膜段螺旋动脉内皮细胞的表达与正常妊娠无明显差别(P>0.05),ET-1在妊高征胎盘床肌层螺旋动脉内皮细胞的表达明显高于正常妊娠(P<0.05)。结论:妊高征时肌层螺旋动脉内皮细胞分泌内皮素明显增多,提示妊高征的发生可能与内皮素的分泌增多有关。 Objective:To observe the expression of ET-1 in placental bed spiral artery of edema-hypertension-proteinuria syndrome patients, and to explore the pathogenesis of edema-hypertension-proteinuria syndrome. Methods: 30 cases of normal pregnancy and 70 cases (among them: 30 cases mild, 20 cases midrange and 20 cases severe ) of edema-hypertension-proteinuria syndrome were investigated. Immunohistochemical technique was used to observe the ET-1 expression in desidual-spiral artery and myo-spiral artery of placental bed. Results: The expression of ET-1 in decidual-spiral artery had no significant differenee between normal pregnancy and edema-hypertension-proteinuria syndrome (P〉 0. 05). While the expression of ET-1 in myo-spiral artery of edema-hypertension-proteinuria syndrome was obviously higher than normal pregnancy (P〈0. 05). Conclusions: In edema-hypertension-protcinuria syndrome, the secretion of ET-1 in myo-spiral artery increased significantly, which indicate that the increasing of ET-1 might play an important role in the development of edema-hypertension-proteinuria syndrome.
出处 《承德医学院学报》 2006年第3期235-237,共3页 Journal of Chengde Medical University
关键词 妊娠高血压综合征 胎盘床 螺旋动脉 ET-1 Edema-hypertension-proteinuria syndrome Placental bed Spiral artery ET-1
  • 相关文献

参考文献7

二级参考文献48

  • 1Carmeliet P, Collen D, Molecular analysis of blood vessel formation and disease[J]. Am J Physiol, 1997, 237:H2091 - 2104.
  • 2Senger DR, Ledbetter SR, Claffey KP, et al. Stimulation of endothelial growth factor through cooperative mechanisms involving the a ν β 3 integrin, osteopomin, and thrombin [ J ]. Am J Pathol, 1996, 149:293 - 305.
  • 3Arispe MLL, Dvorak HF. Angiogenesis:a dynamic balance of stimulators and inhibitors[ J ]. Thromb Haemo. 1997.78 : 672 - 677.
  • 4Vander Zee R, Murbara, T, Luo Z, et al. Vascular endothelial growth factor/vascular permeability factor angments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation[J ], 1997, 95(7) : 1768 - 1772.
  • 5Simpson DA, Murphy GM, Bhaduri T, et al. Biochem Biophys Res Commun, 1999, 262 : 333 - 340.
  • 6Cao Y, Linden P, Shima D, et al. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor[J ]. J Clin Invest, 1996, 98: 2507 - 2511.
  • 7Wheeler T, Evans Pw, Anthony FW, et al. Relationship between maternal serum vascular endothelial growth factor concentration in early pregnancy and fetal and placental growth [J ]. Hum Reprod, 1999, 14(5): 1619 - 1623.
  • 8Cooper JC. Sharkey AM, Charnock - Jones DS, et al. VEGF mR- NA levels in placentae from pregnancies complicated by preeclarnpsia[J]. Br J Obstet Gynecol, 1996, 103(12):1191 - 1196.
  • 9Carmeliet P, Ferreira V, Breier G, et al. Aboormal blood vessel development and lethality in embryos lacking a single VEGF allele [ J ].Nature, 1996, 380:435.
  • 10Neufeld G, Cohen T, Stela G, et al. Vascular endothelial growth factor (VEGF) and its receptors[J]. FASEB J, 1999, 13:9 - 22.

共引文献5

同被引文献28

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部